Dr Andrew Radley

Clinical Reader In Public Health

Population Health and Genomics, School of Medicine

On this page



Andrew Radley is a Consultant Pharmacist in Public Health for NHS Tayside and a Clinical Reader at the University. His clinical activity is focused on maximising the health gain achieved from the medicines and pharmacy resource. He provides leadership for public health themes of tobacco control and pharmaceutical public health.


Current areas of research activity are centred on harnessing the contribution of community pharmacy to improve population health. Ongoing projects include early diagnosis of cancer; reducing drug-related deaths; identifying people with pre-diabetes; implementation of a pharmacogenomic intervention for prescribing in primary care, and improving the quality of care for migraine sufferers.

Andrew is part of an International Collaboration, DESTINE, which aims to eliminate Hepatitis C from Ethiopia and the multi-centre programme, RESCU, which aims to develop a virtual safe drug consumption intervention.

Andrew is currently a CSO Innovation Fellow with the Scottish Health and Industry Partnership. The Fellowship is enabling him to develop community pharmacy infrastructure to enable chronic disease management, using the identification of people with Type 2 Diabetes as a demonstration case.